March 19, 2009 – The 18th annual Interventional Cardiology Symposium will take place June 18-20 in Montreal, Canada.
March 19, 2009 - The Drug Information Association (DIA), in cooperation with the Heart Rhythm Society (HRS) and the FDA, will host Cardiovascular Safety and QT/Arrhythmia Assessment in Drug Development: Optimizing Drug Development Wednesday, April 29 – Friday, May 1 in Bethesda, MD.
March 19, 2009 – The Society of Nuclear Medicine (SNM) will host a two-day symposium Thursday, April 30–Friday, May 1 focused on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-3 in favor of the approval of Multaq (dronedarone) to treat patients with non-permanent atrial fibrillation (AF).
March 19, 2009 – Led by Senator Richard Durbin (D-IL) and Congressman Zack Space (D-OH), the federal government yesterday introduced new legislation that will address the needs of those affected by congenital heart defects (CHDs).
March 19, 2009 - The LUMEN 2009: The Symposium on Optimal Treatments for Acute MI recently hosted hundreds of paramedics, emergency department staff, nurses, internists, hospitalists, interventional cardiologists, cardiac and vascular surgeons, and hospital administrators, to discuss the state of America’s healthcare system and the fight to save vulnerable heart attack patients.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial of IDEV Technologies Inc.’s SUPERA stent, a novel stent platform designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA).
March 19, 2009 - Digisonics will showcase their new DigiView Cath package with its imaging and reporting capabilites for the first time at the ACC 2009 meeting in Orlando, FL at booth #1773.
March 18, 2009 - Flexible Stenting Solutions Inc. (FSS) this week submitted an investigational device exemption (IDE) application to the FDA for its FlexStent Femoropopliteal SE Stent System for the treatment of peripheral artery disease in the superficial femoral and popliteal arteries.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 18, 2009 - Cardiologists Edward Tadajweski, M.D., and Jeffrey L. Williams, M.D., MS, FACC, are the first in the U.S. to perform 3D imaging of complex cardiac anatomy using GE's Innova 3D imaging system.
March 18, 2009 - The U.S. Preventive Services Task Force (USPSTF) found that regular aspirin use reduces first heart attacks in men and first strokes in women and recommends daily aspirin use for certain patient populations.
March 18, 2009 - The success of Massachusetts hospitals and physicians to incorporate information technology (IT) into healthcare demonstrates the importance of incentives, according to two studies conducted by CSC and sponsored by Blue Cross Blue Shield of Massachusetts.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 18, 2009 - GE said yesterday it was awarded two 10-year contracts by the Defense Supply Center Philadelphia (DSCP) to provide products for comprehensive patient monitoring solutions, including acute patient monitoring, networking, telemetry systems, vital signs monitoring. Combined, these two contracts are valued at a maximum of $63 million annually.
March 18, 2009 – The American Heart Association (AHA) is urging Congress to accelerate its efforts to enact comprehensive healthcare reform and increase research funding to prevent setbacks in the fight against heart disease and stroke.
March 18, 2009 - Vicor Technologies Inc. has entered into a collaborative research agreement with the University of Rochester and the Catalan Institute of Cardiovascular Sciences in Barcelona to study sudden cardiac death.